John Libbey Eurotext

The COVID-19 outbreak and approaches to performing EEG in Europe Volume 22, numéro 5, October 2020

Illustrations

  • Figure 1

Tableaux

Auteurs
1 Department of Clinical Neurophysiology, Sahlgrenska University Hospital, Member of the ERN EpiCARE; Institute of Neuroscience and Physiology at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
2 Department of Clinical Neurophysiology, Danish Epilepsy Center, Affiliated partner of the ERN EpiCARE, Dianalund and Aarhus University Hospital; Department of Clinical Medicine, Aarhus University, Denmark
3 Neurophysiology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Member of the ERN EpiCARE, Milan, Italy
4 Department of Paediatric Clinical Epileptology, Sleep Disorders and Functional Neurology, University Hospitals of Lyon (HCL), Member of the ERN EpiCARE Lyon, France
5 Epilepsy Unit, San Juan de Dios Children's Hospital, Member of the ERN EpiCARE, Universitat de Barcelona, Barcelona, Spain
* Correspondence: David Krysl Department of Clinical Neurophysiology, Sahlgrenska University Hospital, Blå Stråket 7, 41345 Gothenburg, Sweden

Aims

The coronavirus SARS-CoV-2 disease (COVID-19) pandemic affects availability and performance of neurophysiological diagnostic methods, including EEG. Our objective was to outline the current situation regarding EEG-based investigations across Europe.